Company Filing History:
6 out of 1,168 
1 out of 92 
1 out of 8 Years Active: 2011-2019
Title: David House: A Notable Innovator in Pharmaceutical Compounds
Introduction
David House, based in Stevenage, Great Britain, is a prominent inventor known for his contributions to the pharmaceutical industry. With a remarkable record of eight patents, House has made significant strides in the development of innovative compounds targeting various medical conditions.
Latest Patents
Among his latest patents is the invention of Pyridinone dicarboxamide for use as bromodomain inhibitors. This invention relates to specific compounds and their pharmaceutical applications in therapy. Another notable patent revolves around Pyrazole compounds that act against allergic, immune, and inflammatory conditions, highlighting his dedication to advancing therapeutic options in the medical field.
Career Highlights
David House has had a distinguished career, having worked with notable companies such as Glaxo Group Limited and GlaxoSmithKline Intellectual Property Limited. His experience in these organizations has undoubtedly contributed to his innovative approaches in drug development and patenting new therapeutic strategies.
Collaborations
Throughout his career, House has collaborated with esteemed colleagues including Anthony William James Cooper and Keith Biggadike. These partnerships have likely facilitated the exchange of ideas and expertise, leading to successful inventions in the pharmaceutical sector.
Conclusion
David House stands as a significant figure in the realm of pharmaceutical innovation. His body of work, marked by substantial patents and collaborations, reflects a commitment to advancing medical treatments and improving patient outcomes. As an inventor, House continues to contribute to the field with his innovative spirit and dedication to research.